Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06). (Q34617414)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06). |
scientific article |
Statements
1 reference
Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06). (English)
1 reference
Dieter Koeberle
1 reference
Michael Montemurro
1 reference
Panagiotis Samaras
1 reference
Pietro Majno
1 reference
Mathew Simcock
1 reference
Andreas Limacher
1 reference
Stefanie Lerch
1 reference
Katalin KovĂ cs
1 reference
Roman Inauen
1 reference
Vivianne Hess
1 reference
Piercarlo Saletti
1 reference
Markus Borner
1 reference
Arnaud Roth
1 reference
György Bodoky
1 reference
4 March 2010
1 reference
1 reference
15
1 reference
3
1 reference
285-292
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference